Global radiopharmaceuticals market was valued at $6.95 billion in 2020 with a CAGR of 8.2% from 2021 to 2027

Global Radiopharmaceuticals Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

Radiopharmaceuticals are a group of pharmaceutical drugs containing radioactive isotopes. Radiopharmaceuticals target specific organs, tissues, or cells within the human body. Radiopharmaceuticals drugs can be used for the diagnosis and for the therapy of diseases.

Note – In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.

Get sample copy of this report @
https://www.infinitybusinessinsights.com/request_sample.php?id=572984

Top key players @ Accuray, C. R. Bard, Elekta, IBA Worldwide, Varian Medical Systems, Carl Zeiss Meditec, iCAD, IsoRay, Mevion Medical Systems, Nordion, NTP Radioisotopes, Canon Medical Systems

Rising prevalence and incidence of cancer and cardiovascular diseases is one of the major factor boosting the market growth. For instance, according to the World Health Organization (WHO), in 2018, around 18.1 million new cancer cases were diagnosed globally, and 9.6 million people died due to cancer. Worldwide, the total number of people alive with 5-year cancer prevalence is around 43.8 million. According to the American Cancer Society, in 2020, an estimate of new cancer cases and deaths accounts for 1.8 million new cancer cases and 606,520 cancer deaths in the United States. According to the Canadian Cancer Society, in 2020, an estimate of 225,800 new cancer cases was diagnosed and 83,300 cancer deaths in Canada. According to the World Health Organization (WHO), each year, more than 3.7 million new cancer cases are diagnosed, and 1.9 million people die from cancer in Europe. According to the World Health Organization (WHO), India accounts for 1.16 million new cancer cases in 2018. In 2018, around 752,000 new cancer cases were diagnosed, and 506,000 died due to cancer in sub-Saharan Africa. According to World Health Organization (WHO), Cardiovascular diseases (CVDs) are the number one cause of death globally, around 17.9 million people die due to cardiovascular diseases each year, an estimate of 31% of deaths globally. More than 75% of cardiovascular diseases deaths occur in lower and middle-income countries. Heart attack and stroke are the cause of 85% of CVD deaths globally. According to the American Heart Association, each year, 720,000 incidences of heart attacks is registered in the United States. In Europe, 3.9 million people die due to cardiovascular disease (CVD) each year.

Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals is the type segment of the market scope. By application the market is divided into Cardiology, Oncology, and Others. By end user the market is further divided into Hospitals, Diagnostic Centers, and Others. The report covers value of the global market by type, application, and end user.

Based on application, Oncology has shown significant growth in 2020, owing to the increasing commercialization of regulatory approved radiopharmaceuticals for oncology, collaboration between companies to develop and distribute radiopharmaceuticals for oncology, rising investment for the development of radiopharmaceuticals for oncology.

TABLE OF CONTENT:
1 Report Overview
2 Global Growth Trends
3 Market Share by Key Players
4 Breakdown Data by Type and Application
5 United States
6 Europe
7 China
8 Japan
9 Southeast Asia
10 India
11 Central & South America
12 International Players Profiles
13 Market Forecasts 2019-2025
14 Analyst’s Viewpoints/Conclusions
15 Appendix

If you have any special requirements, please let us know and we will offer you the report as you want.

About Us:

Infinity Business Insights is a market research company that offers market and business research intelligence all around the world. We are specialized in offering the services in various industry verticals to recognize their highest-value chance, address their most analytical challenges, and alter their work.

We attain particular and niche demand of the industry while stabilize the quantum of standard with specified time and trace crucial movement at both the domestic and universal levels. The particular products and services provided by Infinity Business Insights cover vital technological, scientific and economic developments in industrial, pharmaceutical and high technology companies.

Contact Us:
Amit J
Sales Coordinator
+1-518-300-3575
amit@infinitybusinessinsights.com
https://mobile.twitter.com/IBInsightsLLP
https://facebook.com/Infinity-Business-Insights-352172809160429
https://www.linkedin.com/company/infinity-business-insights/

This release was published on openPR.